AC Bioscience SA

Swiss Biotech Association

Member

AC BioScience Ltd is a clinical stage biotechnology company dedicated to developing innovative therapies for the treatment of tumoral and immunological pathologies.

Products, services, technology

S1P metabolites (ACB2003.4) as an angiogenic therapy for solid hypoxic cancers. Start with clinical trials Phase 2/3 in early 2022 for a combination treatment of metastatic pancreatic adenocarcinoma.
Beta-carboline derivative (ACB1801) to enhance the efficacy of checkpoint-inhibitor immune-therapy.

Location

Route de la Corniche 4, 1066 Epalinges, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2017
Number of employees in Switzerland

1-9

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Praed Pharmaceuticals Ltd

Praed Pharmaceuticals is biopharmaceutical company founded by industry experts. Our mission is to deliver a next generation treatment for Crohn’s disease. We are developing a promising oral compound, cadazolid, for the treatment of Crohn’s disease.
4054 Basel

Member

Philip Morris International

https://www.pmi.com/our-transformation
2000 Neuchâtel

Member

Ymmunobio AG

Ymmunobio AG is a preclinical stage biotechnology company developing a novel class of immune oncology therapeutic antibodies. The proprietary CEACAM1 antibodies are having a direct co-stimulatory effect on immune cells in addition to interfering with the CEACAM1-CEACAM mediated check-point blockade.
4125 Riehen

Member